effect of albumin in pediatric surgery
Phase 3
- Conditions
- congenital heart desease.Patent ductus arteriosus
- Registration Number
- IRCT20180522039787N1
- Lead Sponsor
- Shahid Rajae Cardiovascular and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Parental satisfaction regarding participation in research project
Age 5 days to 2 years
Weight less than or equal to 10 kg
Patients candidated for open heart surgery
Congenital anomaly of the heart
Duration of cardiopulmonary bypass[ for at least one hour and maximum three hours
Exclusion Criteria
Deep hypothermia
low cardiac output
edema or ascites before surgery
Infection and inflammation known a week before surgery
emergency surgery
Not consenting parents to enter the trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Albumin. Timepoint: At the beginning of the study (before the study started) - Immediately in the intensive care unit - 24 hours later in the intensive care unit. Method of measurement: Albumin Measuring Laboratory Kit.;On fluid balance. Timepoint: At the beginning of the study (before the study started) - Immediately in the intensive care unit - 24 hours later in the intensive care unit. Method of measurement: Laboratory kit measuring body electrolytes.
- Secondary Outcome Measures
Name Time Method